Wearing a CGM while you take a GLP-1

What a GLP-1 does to your glucose curve

GLP-1 receptor agonists help the pancreas release insulin when glucose rises after a meal and slow how quickly the stomach empties. MedlinePlus notes that semaglutide slows stomach emptying. The practical result is that food enters your bloodstream more gradually and you feel full sooner.

On a CGM, many people see smaller and slower rises after meals than before starting treatment, and a lower overnight baseline over time. Those changes can be motivating. They also give you a way to see which meals still produce large rises, even on medication.

Three practical uses

• Meal feedback: compare similar meals with and without protein, fiber or a walk afterward
• Under-eating check: long flat stretches with low readings and fatigue can signal you are not eating enough
• Dose changes: notice how your pattern shifts as your clinician adjusts your dose

When low blood sugar is a real concern

GLP-1 medicines on their own rarely cause significant low blood sugar in people without diabetes, because their effect on insulin depends on glucose being raised. The risk rises when they are combined with insulin or sulfonylureas such as glipizide, which push glucose down regardless of what you eat. MedlinePlus advises that other medication doses may need to be adjusted.

If you use either of those medicines, an over-the-counter CGM is not the right tool. The FDA states that the first OTC CGM is not designed to alert users to problematic hypoglycemia. You need a prescription system with alarms and close coordination with the clinician managing your diabetes.

Protecting muscle while eating less

A smaller appetite makes it easy to drift into eating too little protein, which can mean losing muscle along with fat. That matters more after 45, when muscle is harder to rebuild. A CGM cannot measure protein, but a log of what you ate next to your glucose curve can make patterns obvious: skipped meals, long gaps, or days built around small, carbohydrate-heavy snacks.

Your clinician can use that picture to suggest simple changes, such as leading each meal with a protein source and keeping up strength training at least two days a week.

Reading the data without overreacting

CGM readings estimate glucose in tissue fluid and can lag behind blood glucose during rapid changes. A single unusual value is not a reason to change your medication. Confirm unexpected lows with a finger-stick meter if you have one, and look for patterns across several days.

Do not adjust your GLP-1 dose on your own based on CGM data. Share your readings with your clinician, who will consider them alongside your weight trend, side effects and labs.

Side effects to report promptly

GLP-1 medicines commonly cause nausea, vomiting, diarrhea, constipation and heartburn, especially when doses increase. Severe or persistent vomiting can lead to dehydration and should be reported. Seek urgent care for severe upper abdominal pain that may spread to the back, which can signal pancreatitis, or for yellowing skin, fever or pain under the right ribs, which may suggest gallbladder problems.

Semaglutide and tirzepatide carry a boxed warning about thyroid C-cell tumors seen in rodents. They are not used in people with a personal or family history of medullary thyroid carcinoma or multiple endocrine neoplasia type 2. They are not for use in pregnancy.

Before your first sensor

Talk to your clinician about your goals before you start wearing a CGM on a GLP-1. Are you trying to see how meals affect you, check whether you are eating enough, or understand a symptom such as shakiness or fatigue? Having one or two clear questions makes the data far easier to interpret.

Apply the sensor on a day when your dose is stable, so you are not mixing the effects of a dose change with everything else. Log meals, symptoms such as nausea, and your injection days. At review, your clinician can compare your glucose pattern with your side effects and appetite to decide whether any adjustment to your plan, diet or timing makes sense.

Compounded GLP-1s and your CGM plan

If you take a compounded semaglutide or tirzepatide through HealifyMD, remember that compounded medications are not FDA-approved and are not the same as branded products such as Wegovy or Zepbound. A CGM can be a useful extra view of how your body responds, but it does not replace clinician follow-up.

The HealifyMD CGM is $189 one-time (one 14-day sensor, clinician visit included) with no membership fee, confirmed at the eligibility review. Your clinician reviews your data and sends a written summary with practical next steps.